A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis.
Wang WZ, Liu C, Luo JQ, Lei LJ, Chen MH, Zhang YY, Sheng R, Li YN, Wang L, Jiang XH, Xiao TM, Zhang YH, Li SW, Wu YX, Xu Y, Xu YN, Si SY.
Wang WZ, et al. Among authors: zhang yh.
Acta Pharmacol Sin. 2024 May 29. doi: 10.1038/s41401-024-01305-9. Online ahead of print.
Acta Pharmacol Sin. 2024.
PMID: 38811775